AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: nintedanib
Target: Vascular endothelial growth factor receptor 2 (Kinase)
Gene: KDR
UniProt: P35968 (VGFR2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.301
Action type: INHIBITOR
Drug: nintedanib
Target: Vascular endothelial growth factor receptor 3 (Kinase)
Gene: FLT4
UniProt: P35916 (VGFR3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.301
Action type: INHIBITOR
Drug: nintedanib
Target: Platelet-derived growth factor receptor alpha (Kinase)
Gene: PDGFRA
UniProt: P16234 (PGFRA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.745
Action type: INHIBITOR
Drug: nintedanib
Target: Fibroblast growth factor receptor 1 (Kinase)
Gene: FGFR1
UniProt: P11362 (FGFR1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.42
Action type: INHIBITOR
Drug: adalimumab
Target: Tumor necrosis factor (Cytokine)
Gene: TNF
UniProt: P01375 (TNFA_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: pegaptanib
Target: Vascular endothelial growth factor A (Secreted)
Gene: VEGFA
UniProt: P15692 (VEGFA_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Assay: Mechanism of Action
Drug: fimasartan
Target: Type-1 angiotensin II receptor (GPCR)
Gene: AGTR1
UniProt: P30556 (AGTR1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9.377
Action type: ANTAGONIST
Assay: antagonism of angiotensin II induced contraction
Drug: olaparib
Target: Tankyrase-2 (Enzyme)
Gene: TNKS2
UniProt: Q9H2K2 (TNKS2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.28
Assay: Enzyme Assay: In order to test the selectivity of substituents on piperazinotriazole ring within the PARP family, the selectivity of compound S3 and positive compound AZD2281 were tested.
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 4 (Enzyme)
Gene: PARP4
UniProt: Q9UKK3 (PARP4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.39
Assay: Inhibition of recombinant human His6-tagged PARP4 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 10 (Enzyme)
Gene: PARP10
UniProt: Q53GL7 (PAR10_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.9
Assay: Inhibition of recombinant human His6-tagged PARP10 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 12 (Enzyme)
Gene: PARP12
UniProt: Q9H0J9 (PAR12_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5
Assay: Inhibition of recombinant human His6-tagged PARP12 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 15 (Enzyme)
Gene: PARP15
UniProt: Q460N3 (PAR15_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.75
Assay: Inhibition of recombinant human His6-tagged PARP15 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 6 (Unclassified)
Gene: PARP6
UniProt: Q2NL67 (PARP6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.75
Assay: Inhibition of full length human PARP6 expressed in a Baculovirus infected Sf9 insect cells using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay
Drug: olaparib
Target: Mono [ADP-ribose] polymerase PARP16 (Unclassified)
Gene: PARP16
UniProt: Q8N5Y8 (PAR16_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.29
Assay: Inhibition of full length recombinant human His6-tagged PARP16 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay
Drug: olaparib
Target: Tankyrase-1 (Enzyme)
Gene: TNKS
UniProt: O95271 (TNKS1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.824
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 2 (Enzyme)
Gene: PARP2
UniProt: Q9UGN5 (PARP2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9
Action type: INHIBITOR
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 1 (Enzyme)
Gene: PARP1
UniProt: P09874 (PARP1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.301
Action type: INHIBITOR
Drug: olaparib
Target: Poly [ADP-ribose] polymerase 3 (Enzyme)
Gene: PARP3
UniProt: Q9Y6F1 (PARP3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.34
Action type: INHIBITOR
Assay: Inhibition of PARP3 (unknown origin) using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay
Drug: acotiamide
Target: Acetylcholinesterase (Enzyme)
Gene: ACHE
UniProt: P22303 (ACES_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.523
Action type: INHIBITOR
Assay: recombinant human AChE
Drug: alemtuzumab
Target: CAMPATH-1 antigen (Surface antigen)
Gene: CD52
UniProt: P31358 (CD52_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: felypressin
Target: Vasopressin V1a receptor (GPCR)
Gene: AVPR1A
UniProt: P37288 (V1AR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: ombitasvir
Target: Nonstructural protein 5A (Unclassified)
Gene: NS5A
UniProt: Q5L478 (Q5L478_9HEPC)
Organism: Hepatitis C virus
Activity: EC50 = 10.85
Assay: Inhibition of NS5A in HuH7 cell infected HCV genotype 1a H77 assessed as decrease in viral replication after 3 days by luciferase reporter gene assay
Drug: ombitasvir
Target: Genome polyprotein [Cleaved into: Core protein p21 (Unclassified)
UniProt: Q9WMX2 (POLG_HCVCO)
Organism: Hepatitis C virus genotype 1b
Activity: EC50 = 10.92
Assay: Inhibition of HCV genotype 1b Con1 NS5A expressed in HuH7 cell infected HCV genotype 2a assessed as decrease in viral replication after 3 days by luciferase reporter gene assay
Drug: ombitasvir
Target: Genome polyprotein (Polyprotein)
UniProt: P26663 (POLG_HCVBK)
Organism: Hepatitis C virus genotype 1b (isolate BK)
Activity: EC50 = 11.301
Action type: INHIBITOR
Assay: in vitro replicon assay
Drug: ombitasvir
Target: Genome polyprotein (Polyprotein)
UniProt: P27958 (POLG_HCVH)
Organism: Hepatitis C virus genotype 1a (isolate H)
Activity: EC50 = 10.854
Action type: INHIBITOR
Assay: in vitro replicon assay
Drug: dasabuvir
Target: NS5B protein (Enzyme)
Gene: NS5B
UniProt: Q8JXU8 (Q8JXU8_9HEPC)
Organism: Hepatitis C virus
Activity: EC50 = 8.74
Assay: Inhibition of HCV genotype 1b NS5B RNA dependent RNA polymerase
Drug: dasabuvir
Target: NS5B protein (Unclassified)
Gene: NS5B
UniProt: Q8JXU8 (Q8JXU8_9HEPC)
Organism: Hepatitis C virus
Activity: EC50 = 8.74
Assay: Inhibition of HCV genotype 1b NS5B RNA dependent RNA polymerase
Drug: blinatumomab
Target: B-lymphocyte antigen CD19 (Surface antigen)
Gene: CD19
UniProt: P15391 (CD19_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9
Action type: ANTIBODY BINDING
Assay: Binding of the single-chain Fv portion of blinatumomab to CD19.
Drug: blinatumomab
Target: T-cell surface glycoprotein CD3 (Surface antigen)
Gene: CD3E|CD3G|CD3D
UniProt: P07766|P09693|P04234 (CD3E_HUMAN|CD3G_HUMAN|CD3D_HUMAN)
Organism: Homo sapiens
Activity: Kd = 7
Action type: ANTIBODY BINDING
Assay: Binding of the single-chain Fv portion of blinatumomab to CD3.
Drug: aflibercept
Target: Vascular endothelial growth factor A (Secreted)
Gene: VEGFA
UniProt: P15692 (VEGFA_HUMAN)
Organism: Homo sapiens
Activity: Kd = 12.301
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: aflibercept
Target: Placenta growth factor (Secreted)
Gene: PGF
UniProt: P49763 (PLGF_HUMAN)
Organism: Homo sapiens
Activity: Kd = 10.409
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: aflibercept
Target: Vascular endothelial growth factor B (Secreted)
Gene: VEGFB
UniProt: P49765 (VEGFB_HUMAN)
Organism: Homo sapiens
Activity: Kd = 11.717
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: ramucirumab
Target: Vascular endothelial growth factor receptor 2 (Kinase)
Gene: KDR
UniProt: P35968 (VGFR2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 10.3
Action type: ANTIBODY BINDING
Drug: safinamide
Target: Sodium channel protein type 9 subunit alpha (Ion channel)
Gene: SCN9A
UniProt: Q15858 (SCN9A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.48
Assay: Inhibition of tetrodotoxin-sensitive Na+ channel at -50 mV membrane holding potential by patch-clamp electrophysiology
Drug: safinamide
Target: Amine oxidase [flavin-containing] A (Enzyme)
Gene: MAOA
UniProt: P21397 (AOFA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.35
Drug: safinamide
Target: Sigma non-opioid intracellular receptor 1 (Membrane receptor)
Gene: Sigmar1
UniProt: Q9R0C9 (SGMR1_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 7.71
Assay: Inhibition of [3H]pentazocine binding to Opioid receptor sigma 1
Drug: safinamide
Target: Amine oxidase [flavin-containing] B (Enzyme)
Gene: Maob
UniProt: P19643 (AOFB_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 7.59
Assay: Inhibition of MAO-B in mitochondria-enriched Sprague-Dawley rat liver fractions using p-tyramine as substrate incubated for 30 mins prior to substrate addition measured for 45 mins by amplex red reagent-based microplate fluorescence reader analysis
Drug: safinamide
Target: Sodium channel alpha subunits; brain (Types I, II, III) (Ion channel)
Gene: Scn1a|Scn2a|Scn3a
UniProt: P04774|P04775|P08104 (SCN1A_RAT|SCN2A_RAT|SCN3A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 5.09
Assay: Binding of [3H]batrachotoxin (BTX) to rat brain sodium channel
Drug: safinamide
Target: Amine oxidase [flavin-containing] B (Enzyme)
Gene: MAOB
UniProt: P27338 (AOFB_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.347
Action type: INHIBITOR
Assay: human recombinant MAO B
Drug: nivolumab
Target: Programmed cell death protein 1 (Membrane receptor)
Gene: PDCD1
UniProt: Q15116 (PDCD1_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.14
Action type: ANTIBODY BINDING
Drug: pembrolizumab
Target: Programmed cell death protein 1 (Membrane receptor)
Gene: PDCD1
UniProt: Q15116 (PDCD1_HUMAN)
Organism: Homo sapiens
Activity: Kd ~ 10
Action type: ANTIBODY BINDING
Drug: becaplermin
Target: Platelet-derived growth factor receptor (Kinase)
Gene: PDGFRB|PDGFRA
UniProt: P09619|P16234 (PGFRB_HUMAN|PGFRA_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: albiglutide
Target: Glucagon-like peptide 1 receptor (GPCR)
Gene: Glp1r
UniProt: P32301 (GLP1R_RAT)
Organism: Rattus norvegicus
Activity: EC50 = 7.7
Action type: AGONIST
Drug: albiglutide
Target: Glucagon-like peptide 1 receptor (GPCR)
Gene: GLP1R
UniProt: P43220 (GLP1R_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 9.699
Action type: AGONIST
Drug: follitropin
Target: Follicle-stimulating hormone receptor (GPCR)
Gene: FSHR
UniProt: P23945 (FSHR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: lutropin alfa
Target: Lutropin-choriogonadotropic hormone receptor (GPCR)
Gene: LHCGR
UniProt: P22888 (LSHR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 10.9
Action type: AGONIST
Drug: thyrotropin alfa
Target: Thyrotropin receptor (GPCR)
Gene: TSHR
UniProt: P16473 (TSHR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: corticotropin
Target: Melanocortin receptor 4 (GPCR)
Gene: MC4R
UniProt: P32245 (MC4R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.16
Action type: AGONIST
Drug: corticotropin
Target: Melanocortin receptor 3 (GPCR)
Gene: MC3R
UniProt: P41968 (MC3R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.06
Action type: AGONIST
Drug: corticotropin
Target: Melanocyte-stimulating hormone receptor (GPCR)
Gene: MC1R
UniProt: Q01726 (MSHR_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.6
Action type: AGONIST
Drug: corticotropin
Target: Adrenocorticotropic hormone receptor (GPCR)
Gene: MC2R
UniProt: Q01718 (ACTHR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Drug: corticotropin
Target: Adrenocorticotropic hormone receptor (GPCR)
Gene: Mc2r
UniProt: Q64326 (ACTHR_MOUSE)
Organism: Mus musculus
Activity: Kd = 9.8
Action type: AGONIST
Drug: tocilizumab
Target: Interleukin-6 receptor (Membrane receptor)
Gene: IL6R|IL6ST
UniProt: P08887|P40189 (IL6RA_HUMAN|IL6RB_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: secukinumab
Target: Interleukin-17A (Cytokine)
Gene: IL17A
UniProt: Q16552 (IL17_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: palivizumab
Target: Fusion glycoprotein F0 (Surface antigen)
Gene: F
UniProt: P03420 (FUS_HRSVA)
Organism: Human respiratory syncytial virus A (strain A2)
Activity: EC50 = 5.357
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: parathyroid hormone
Target: Parathyroid hormone/parathyroid hormone-related peptide receptor (GPCR)
Gene: PTH1R
UniProt: Q03431 (PTH1R_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: alectinib
Target: Vascular endothelial growth factor receptor 2 (Kinase)
Gene: KDR
UniProt: P35968 (VGFR2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.85
Assay: Inhibition of KDR using Bio-Gastrintide as substrate by TR-FRET assay in presence of 50 uM of ATP
Drug: alectinib
Target: SRSF protein kinase 1 (Kinase)
Gene: SRPK1
UniProt: Q96SB4 (SRPK1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.71
Assay: Inhibition of SRPK1 (unknown origin) by TR-FRET assay
Drug: alectinib
Target: Proto-oncogene tyrosine-protein kinase ROS (Kinase)
Gene: ROS1
UniProt: P08922 (ROS1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.7
Assay: Inhibition of ROS1 L2026M mutant (unknown origin)
Drug: alectinib
Target: ALK tyrosine kinase receptor (Kinase)
Gene: ALK
UniProt: Q9UM73 (ALK_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.721
Action type: INHIBITOR
Assay: TR-FRET in vitro assay ATP concentration 30uM
Drug: alectinib
Target: Proto-oncogene tyrosine-protein kinase receptor Ret (Kinase)
Gene: RET
UniProt: P07949 (RET_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.319
Action type: INHIBITOR
Assay: time-resolved fluorescence resonance energy transfer assay to examine each compound’s ability to phosphorylate substrate peptide Biotin-EGPWLEEEEEAYGWMDF in the presence of the drug and 30 umol/L ATP
Drug: ripasudil
Target: cAMP-dependent protein kinase catalytic subunit alpha (Kinase)
Gene: PRKACA
UniProt: P17612 (KAPCA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.68
Action type: INHIBITOR
Drug: ripasudil
Target: Rho-associated protein kinase 1 (Kinase)
Gene: ROCK1
UniProt: Q13464 (ROCK1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.292
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: ripasudil
Target: Rho-associated protein kinase 2 (Kinase)
Gene: ROCK2
UniProt: O75116 (ROCK2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.721
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: vaniprevir
Target: Cathepsin S (Enzyme)
Gene: CTSS
UniProt: P25774 (CATS_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.11
Assay: Inhibition of human cathepsin S
Drug: vaniprevir
Target: Nonstructural protein NS3-4A (Unclassified)
UniProt: A0A0K1CY61 (A0A0K1CY61_9HEPC)
Organism: Hepatitis C virus
Activity: Ki = 10.3
Drug: vaniprevir
Target: Genome polyprotein (Unclassified)
UniProt: K7XJL6 (K7XJL6_9HEPC)
Organism: Hepacivirus C
Activity: Ki = 7.66
Assay: Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence analysis
Drug: vaniprevir
Target: Genome polyprotein (Polyprotein)
UniProt: P26663 (POLG_HCVBK)
Organism: Hepatitis C virus genotype 1b (isolate BK)
Activity: Ki = 10.301
Action type: INHIBITOR
Assay: in vitro NS3 mediated hydrolysis of the peptide substrate using time-resolved fluorescence assay
Drug: vaniprevir
Target: Genome polyprotein (Polyprotein)
UniProt: Q99IB8 (POLG_HCVJF)
Organism: Hepatitis C virus genotype 2a (isolate JFH-1)
Activity: Ki = 9.046
Action type: INHIBITOR
Assay: in vitro NS3 mediated hydrolysis of the peptide substrate using time-resolved fluorescence assay
Drug: basiliximab
Target: Interleukin-2 receptor subunit alpha (Membrane receptor)
Gene: IL2RA
UniProt: P01589 (IL2RA_HUMAN)
Organism: Homo sapiens
Activity: Kd = 10
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: palbociclib
Target: Tyrosine-protein kinase JAK3 (Kinase)
Gene: JAK3
UniProt: P52333 (JAK3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.2
Assay: Inhibition of JAK3 (unknown origin)
Drug: palbociclib
Target: Receptor-type tyrosine-protein kinase FLT3 (Kinase)
Gene: FLT3
UniProt: P36888 (FLT3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.46
Assay: Inhibition of GST-fused human FLT3 cytoplasmic domain (amino acids 564 to 993) using Ulight-JAK1 as substrate after 1 hr by TR-FRET assay
Drug: palbociclib
Target: Cyclin-dependent kinase 9 (Kinase)
Gene: CDK9
UniProt: P50750 (CDK9_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.1
Assay: Inhibition of CDK9 (unknown origin)
Drug: palbociclib
Target: Cyclin-dependent kinase 4/cyclin D1 (Kinase)
Gene: CDK4|CCND1
UniProt: P11802|P24385 (CDK4_HUMAN|CCND1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.7
Assay: Inhibition of CDK4/cyclin D1 (unknown origin) using Rb as substrate after 60 mins by scintillation counting analysis in presence of [r-33P]ATP
Drug: palbociclib
Target: CDK2/Cyclin A (Kinase)
Gene: CCNA2|CDK2
UniProt: P20248|P24941 (CCNA2_HUMAN|CDK2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.64
Assay: Inhibition of CDK2/cyclinA (unknown origin)
Drug: palbociclib
Target: CDK6/cyclin D1 (Kinase)
Gene: CCND1|CDK6
UniProt: P24385|Q00534 (CCND1_HUMAN|CDK6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.42
Assay: Inhibition of CDK6/cyclinD1 (unknown origin)
Drug: palbociclib
Target: Ribosomal protein S6 kinase alpha-1 (Kinase)
Gene: RPS6KA1
UniProt: Q15418 (KS6A1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.097
Action type: INHIBITOR
Drug: palbociclib
Target: Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Kinase)
Gene: DYRK1A
UniProt: Q13627 (DYR1A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.699
Action type: INHIBITOR
Drug: palbociclib
Target: Cyclin-dependent kinase 6 (Kinase)
Gene: CDK6
UniProt: Q00534 (CDK6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.824
Action type: INHIBITOR
Assay: Cdk6/cyclin D2
Drug: palbociclib
Target: Cyclin-dependent kinase 4 (Kinase)
Gene: CDK4
UniProt: P11802 (CDK4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.959
Action type: INHIBITOR
Assay: Cdk4/cyclin D1
Drug: lenvatinib
Target: Carbonic anhydrase 5A, mitochondrial (Enzyme)
Gene: CA5A
UniProt: P35218 (CAH5A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.88
Assay: Inhibition of recombinant human carbonic anhydrase VA preincubated with enzyme for 15 mins by phenol red dye based stopped flow CO2 hydration assay
Drug: lenvatinib
Target: Platelet-derived growth factor receptor beta (Kinase)
Gene: PDGFRB
UniProt: P09619 (PGFRB_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.409
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Epidermal growth factor receptor (Kinase)
Gene: EGFR
UniProt: P00533 (EGFR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.187
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Proto-oncogene tyrosine-protein kinase receptor Ret (Kinase)
Gene: RET
UniProt: P07949 (RET_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.82
Action type: INHIBITOR
Assay: Inhibition of RET (unknown origin)
Drug: lenvatinib
Target: Mast/stem cell growth factor receptor Kit (Kinase)
Gene: KIT
UniProt: P10721 (KIT_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Vascular endothelial growth factor receptor 1 (Kinase)
Gene: FLT1
UniProt: P17948 (VGFR1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.658
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Vascular endothelial growth factor receptor 2 (Kinase)
Gene: KDR
UniProt: P35968 (VGFR2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.398
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Vascular endothelial growth factor receptor 3 (Kinase)
Gene: FLT4
UniProt: P35916 (VGFR3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.284
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Platelet-derived growth factor receptor alpha (Kinase)
Gene: PDGFRA
UniProt: P16234 (PGFRA_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.292
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: lenvatinib
Target: Fibroblast growth factor receptor 1 (Kinase)
Gene: FGFR1
UniProt: P11362 (FGFR1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.337
Action type: INHIBITOR
Assay: in vitro kinase activity at 1uM ATP
Drug: arformoterol
Target: Beta-3 adrenergic receptor (GPCR)
Gene: ADRB3
UniProt: P13945 (ADRB3_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 7.6
Assay: Agonist activity at human beta3 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay
Drug: arformoterol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: Adrb2
UniProt: Q8K4Z4 (ADRB2_CAVPO)
Organism: Cavia porcellus
Activity: EC50 = 9.9
Assay: Agonist activity at guinea pig trachea beta2-adrenergic receptor assessed as relaxation of histamine-induced tracheal ring contraction
Drug: arformoterol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Kd = 6.947
Action type: AGONIST
Assay: displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug: arformoterol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.538
Action type: AGONIST
Assay: displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2
Drug: pancreozymin
Target: Cholecystokinin receptor type A (GPCR)
Gene: CCKAR
UniProt: P32238 (CCKAR_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 10
Assay: Compound was evaluated for the [Ca2+] mobilization innstably transfected CHO-K1 cell lines expressing human Cholecystokinin type A receptor
Drug: pancreozymin
Target: Gastrin/cholecystokinin type B receptor (GPCR)
Gene: CCKBR
UniProt: P32239 (GASR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.8
Action type: AGONIST
Drug: pancreozymin
Target: Cholecystokinin receptor type A (GPCR)
Gene: Cckar
UniProt: P30551 (CCKAR_RAT)
Organism: Rattus norvegicus
Activity: Kd = 9.3
Action type: AGONIST
Drug: pancreozymin
Target: Gastrin/cholecystokinin type B receptor (GPCR)
Gene: Cckbr
UniProt: P30553 (GASR_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.39
Assay: Binding affinity for Cholecystokinin type B receptor using [125I]-BH-CCK-8 in rat cortex synaptosomes
Drug: pancreozymin
Target: Gastrin/cholecystokinin type B receptor (GPCR)
Gene: Cckbr
UniProt: P56481 (GASR_MOUSE)
Organism: Mus musculus
Activity: IC50 = 9.52
Assay: Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex
Drug: pancreozymin
Target: Cholecystokinin receptor type A (GPCR)
Gene: CCKAR
UniProt: Q63931 (CCKAR_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 9.55
Assay: Inhibition of [3H]pCCK-8 binding to Cholecystokinin type A receptor of Guinea pig pancreatic membranes
Drug: avibactam
Target: Penicillin-binding protein 2 (Enzyme)
Gene: mrdA
UniProt: P0AD65 (PBP2_ECOLI)
Organism: Escherichia coli (strain K12)
Activity: IC50 = 6.23
Assay: Inhibition of bocillin-FL binding to Escherichia coli K12 NusA-fused/His6-tagged PBP2 (57 to 615 residues) expressed in Escherichia coli BL21(DE3) preincubated for 30 mins followed by bocillin-FL addition by RT-fluorescence anisotropy method
Drug: avibactam
Target: Beta-lactamase (Enzyme)
Gene: ampC
UniProt: P05364 (AMPC_ENTCL)
Organism: Enterobacter cloacae
Activity: Kd = 8.155
Action type: INHIBITOR
Drug: avibactam
Target: Beta-lactamase (Enzyme)
Gene: ampC
UniProt: P24735 (AMPC_PSEAE)
Organism: Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Activity: Kd = 6.18
Action type: INHIBITOR
Drug: avibactam
Target: Beta-lactamase (Enzyme)
Gene: blaUOE-1
UniProt: Q9EXV5 (Q9EXV5_ECOLX)
Organism: Escherichia coli
Activity: Kd = 8.699
Action type: INHIBITOR